来曲唑在乳腺癌术后新辅助内分泌治疗中的近期疗效评价被引量：4

导出

摘要目的探讨来曲唑在乳腺癌术后新辅助内分泌治疗的近期疗效。方法选取我院2012年4月至2013年7月行乳腺癌根治术的40例患者进行分析,分别于术后行新辅助内分泌治疗,随机分为治疗组(来曲唑治疗)与对照组(枸橼酸他莫昔芬治疗),各20例。结果治疗组总缓解率为65.0%,对照组总缓解率为35.0%,两组比较差异有统计学意义(P<0.05)。结论来曲唑作为乳腺癌术后新辅助内分泌的治疗,疗效较好,不良反应少,安全性高,可有效提高乳腺癌的局部控制率和保乳率。

作者陈光

机构地区长春市中心医院肿瘤科

出处《中国药物经济学》 2014年第9期14-15,共2页 China Journal of Pharmaceutical Economics

关键词来曲唑枸橼酸他莫昔芬乳腺癌疗效

分类号 R737.9 [医药卫生—肿瘤]

引文网络
相关文献

参考文献2

1芦珊,周玮.来曲唑在老年乳腺癌新辅助内分泌治疗中的疗效观察[J].实用癌症杂志,2012,27(6):632-634. 被引量：10
2张柳春.来曲唑在乳腺癌新辅助内分泌治疗中的应用和疗效观察[J].海峡药学,2012,24(12):177-178. 被引量：4

二级参考文献13

1Fisher ER,Wang J,Bryant J,et al,Pathobiology of preoperative chemoterapy:findings from the National Surgical Adjuvant Breast and Bowel (NSABP)protocol B-19[J].Cancer,2002.95(4):681.
2Seminglazov VF,Semiglazov VV.Dashyan GA,er al.Phas 2 randomized trial of primary endocrime theapy vetsus chemotherpy in postmenopausal patients weth estrogen ree eptor-positive brast cancer[J],Cancer,2007.110(2):224.
3Mouridsen H, Gershanovich M, Sun Y, et al. Superior effica- cy of letrozole versus tamoxifen as first-line therapy for post- menopausal women with advanced breast eaneer:resuhs of a phase Ⅲ study of the International Letrozole Breast Cancer Group [ J ]. J Clin Oneol, 2001,19 ( 10 ) : 2596.
4Dixon JM, Anderson TJ, Miller WR, et al. Neoadjuvant en- doerine therapy of breast eancer:a surgieal perspective [J]. Enr J Cancer ,2002,38 (17) :2214.
5Miller WR, Dixon JM, Cameron DA, et al. Biologieal and elinical effects of aromatase inhibitors in neoadjuvant thera- py[ J]. J Steroid Bioehem Mol Bio1,2001,79 (1-5 ) :103.
6W Eiennann, S Paepke, J Appfelstaedt, et al. Preoperative treatment of postmenopausal breast cancer patients with letrozole : A randomized double-blind muhieenter study[J]. Ann Oneol,2001,12 ( 11 ) : 1527.
7Ellis M J, Tao Y, Young O, White S, et al. Estrogen-inde- pendent proliferation is present in estrogen-receptor HER2- positive primary breast cancer after neoadjuvant letrozo, e [J]. J Clin Oncol,2006,24(19) :3019.
8Smith IE, Dowsett M, Ebbs SR, et al. Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination:the Immediate Preoperative Anastro- zole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial[ J]. J Clin Oncol, 2005,23 (22) :5108.
9李荣萍,任佳,吕文静,张立娜,刘峰.来曲唑在绝经后乳腺癌新辅助内分泌治疗中的应用[J].山东医药,2009,49(32):67-69. 被引量：8
10孙迪文.新辅助化疗后乳腺癌组织中survivin表达及其与Ki-67、AI的相关性研究[J].实用癌症杂志,2010,25(2):126-128. 被引量：5